tyrosine and pd 173074

tyrosine has been researched along with pd 173074 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darvann, T; Morriss-Kay, G; Ornitz, DM; Perlyn, CA; Tenenbaum, M1
Benitez, JA; Boyer, A; Cavenee, WK; Chen, CC; DeGroot, J; Fenton, TR; Furnari, FB; Gahman, TC; Galatro, T; Koga, T; Kolodner, RD; Li, J; Lindahl, E; Ma, J; Miki, S; Nagahashi Marie, SK; Orellana, L; Ponte de Albuquerque, C; Reed, R; Shiau, AK; Sulman, EP; Varki, NM; Zanca, C; Zhou, H1

Other Studies

2 other study(ies) available for tyrosine and pd 173074

ArticleYear
A model for the pharmacological treatment of crouzon syndrome.
    Neurosurgery, 2006, Volume: 59, Issue:1

    Topics: Animals; Cranial Sutures; Craniofacial Dysostosis; Cysteine; Disease Models, Animal; Mice; Mice, Mutant Strains; Mutation; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Tissue Culture Techniques; Tomography, X-Ray Computed; Tyrosine

2006
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
    Cancer cell, 2019, 03-18, Volume: 35, Issue:3

    Topics: Animals; Brain Neoplasms; Cell Nucleus; DNA Repair; Female; Glioma; Humans; Male; Mice; Phosphorylation; PTEN Phosphohydrolase; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine; Xenograft Model Antitumor Assays

2019